-
New Mesothelioma Study – Asbestos related cancer
-
The Dartmouth Medical School’s study may provide a new hope for patients facing the asbestos related cancer mesothelioma. The school which is based in New Hampshire, USA completed studies based on past work performed with methylthioadenosine phosphorylase (MTAP). A missing enzyme linked to several types of cancers including lung cancer, pancreatic cancer, Leukemia, Lymphoma and mesothelioma, researchers found that MTAP may be linked to the development of malignant tumors in those who lack the enzyme.
The study lead by Dr. Martin Lubin and Adam Lubin, researchers from the university, utilised two powerful chemical agents to form a treatment which may destroy tumours whilst protecting healthy cells.
The first agent, thioguanine, is a highly toxic drug that can damage both cancerous and healthy cells, whilst the other drug, fluorouracil, protects healthy tissues from the first agent’s toxicity. Both of these drugs are already in clinical use but are administered in low doses due to the high potency of the medications.
Although in its early stages, the study demonstrates the possibility of attacking tumors that are resistant to these drugs, whilst still protecting healthy tissue. Dr. Lubin believes that successful animal studies will lead to clinical use as soon as possible.
The condition of malignant mesothelioma typically develops after exposure to asbestos. When toxic asbestos fibres are inhaled, they may become lodged in organs or body cavities, causing inflammation or infection. Many patients do not demonstrate symptoms of the cancer for 20 to 50 years after initial exposure occurred, allowing mesothelioma to progress to later stages of development. There is no cure for mesothelioma however treatment options are available such as radiation; chemotherapy and surgery are available to prolong the sufferers’ life.
If you have been diagnosed with mesothelioma and you believe you contracted this disease due to the negligence of a third party you could be entitled to compensation. Give our occupational disease and illness solicitors a call on 0800 634 1632 or send your query via email using our online form.
This article was written by Helen England, Solicitor, Occupational Illness Team.
Useful info:
-
Emma Costin
-
16/09/2009
Disclaimer: No information on this website shall be construed as
legal advice and information is offered for general information purposes only based on the current law when the information was first displayed on this website. You should
always seek advice from an appropriately qualified solicitor on any specific legal
enquiry. Calls to or from our legal helpline may be recorded for training and monitoring purposes.
External links are provided for your convenience, but they are beyond the control
of Simpson Millar LLP and no representation is made as to their content. Use or
reliance on any external links and the content thereon provided is at your own risk.
Full terms of use...